mk-8150
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 7, 2012 (NCT01590810)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Cytochrome P450 3A43ACTIVATOR
CYP3A43 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mk-8150
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01656408 | Phase 1 | Aug 1, 2012 | Merck |
| NCT01590810 | Phase 1 | May 7, 2012 | Merck |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 2 | 2 | 1 | 2012 |
1 organizations
Page 1 / 1